BRIEF published on 09/30/2024 at 18:05, 1 year 2 months ago EXACOMPTA CLAIREFONTAINE validates its eligibility for PEA-PME PEA-PME Investment Euronext Growth Exacompta Clairefontaine Eligibility
REGULATED PRESS RELEASE published on 09/27/2024 at 18:00, 1 year 2 months ago Financial statements - 30 june 2024
BRIEF published on 09/23/2024 at 18:05, 1 year 2 months ago EXACOMPTA CLAIREFONTAINE Reports H1 2024 Financial Results Financial Results Revenue Net Income Operating Income Exacompta Clairefontaine
REGULATED PRESS RELEASE published on 09/23/2024 at 18:00, 1 year 2 months ago Financial statements - 30 june 2024 EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2024, showing revenue of €408,424 and net income of €16,504 Financial Statements Revenue Net Income Exacompta Clairefontaine H1 2024
BRIEF published on 09/19/2024 at 18:05, 1 year 2 months ago EXACOMPTA CLAIREFONTAINE Half-Year Report 2024 Operating Result Turnover Debt Exacompta Clairefontaine Paper Sector
BRIEF published on 04/02/2024 at 18:05, 1 year 8 months ago EXACOMPTA CLAIREFONTAINE Reports Strong Financial Results for 2023 Financial Results Revenue Growth Dividend Exacompta Clairefontaine Stationery Market
REGULATED PRESS RELEASE published on 04/02/2024 at 18:00, 1 year 8 months ago Financial statements - 31 december 2023 EXACOMPTA CLAIREFONTAINE reports 2023 financial results with €843.2M revenue and €72.1M operating income. Decline in paper demand in Europe observed. Outlook uncertain with pulp prices rising and energy costs increasing Financial Results Revenue Exacompta Clairefontaine Paper Demand Pulp Prices
BRIEF published on 03/28/2024 at 18:05, 1 year 8 months ago EXACOMPTA CLAIREFONTAINE presents its 2023 financial results and outlook 2023 Results Financial Perspective Exacompta Clairefontaine Paper Sector Stationery Market
BRIEF published on 03/08/2024 at 18:05, 1 year 8 months ago Evolution of voting rights and shares at EXACOMPTA CLAIREFONTAINE in 2023 Voting Rights Actions AMF Exacompta Clairefontaine Evolution 2023
BRIEF published on 03/07/2024 at 18:05, 1 year 8 months ago Exacompta Clairefontaine SA announces the acquisition of FLOCK ONE SAS Acquisition Exacompta Clairefontaine FLOCK ONE SAS Flocking
Published on 12/05/2025 at 02:35, 5 hours 11 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 46 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 41 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 46 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 46 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 16 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 55 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 21 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 31 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 46 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 1 minute ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 2 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
